IMR Press / CEOG / Volume 24 / Issue 1 / pii/1997001

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research

Similar pregnancy and spontaneous abortion rates after treatment with low-dose human menopausal gonadotropin versus pure follicle stimulating hormone in women with lute al phase defects

Show Less
1 Cooper Medical School of Rowan University, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ (USA)
Clin. Exp. Obstet. Gynecol. 1997, 24(1), 5–7;
Published: 10 March 1997
Abstract

The study presented herewith was designed to compare the pregnancy and abortion rates in patients treated with gonadotropin preparations with and without LH content based on data suggesting that higher serum LH levels during the follicular phase may reduce subsequent pregnancy rates and increase spontaneous abortion rates. Infertile patients with luteal phase defects related to releasing eggs prior to complete follicular maturation were treated with either ultra-low dose (75 IU) hMG or pure FSH. The pre­gnancy rates for first treatment cycles for hMG versus pure FSH was 22.7% and 20.3%, respectively. The spontaneous abortion rates were also similar (8.0% and 9.1 %). There were no multiple births resulting from these 36 pregnancies. Ovarian hyperstimu­lation syndrome was not observed in any of the I 64 stimulation cycles. Thus these results show no advantage in choosing a prepa­ration devoid of LH therefore giving the patient the opportunity to purchase the least expensive medication that is available.

Keywords
Luteinizing hormone
Pregnancies
Multiple births
Gonadotropins
Abortions
Share
Back to top